MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,867 | $7,428,617 | 1.35% |
| Baker Brothers Advisors | 1,545,113 | $225,648,303 | 1.30% |
| AtonRa Partners | 3,857 | $563,276 | 1.18% |
| RTW INVESTMENTS, LP | 309,485 | $45,197,189 | 0.95% |
| Monashee Investment Management LLC | 15,000 | $2,190,600 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 18,300 | $2,669,421 | 0.90% |
| Knott David M Jr | 15,000 | $2,191 | 0.84% |
| Orbimed Advisors | 253,309 | $36,993,246 | 0.79% |
| Boxer Capital, LLC | 100,000 | $14,604,000 | 0.78% |
| Rock Springs Capital Management LP | 196,369 | $28,677,729 | 0.77% |
External links
This page lists MADRIGAL PHARMACEUTICALS INC's shareholders in Q3 2023. To view MADRIGAL PHARMACEUTICALS INC's shareholder history, click here.